• Magnetic Nano-Antibody Enables In Vivo CAR-T-Mimicking Thera

  2026-04-30

  This study introduces a magnetic bispecific nano-antibody (M-BiNanoAb) system for the in vivo generation and targeted guidance of CAR-T-mimicking cells, overcoming key limitations in solid tumor immunotherapy. The approach bypasses ex vivo T cell engineering, enabling precise, magnetically directed tumor infiltration and demonstrating improved antitumor efficacy in preclinical models.

• Periodontopathogen Proteases Redirect RAS to Generate Angiot

  2026-04-30

  This study reveals that key oral pathogens, Porphyromonas gingivalis and Tannerella forsythia, can enzymatically convert angiotensin I to angiotensin (1-7) via unique surface-attached proteases. These findings highlight a microbial influence on local and systemic renin–angiotensin system (RAS) regulation, with implications for understanding periodontitis-associated comorbidities.

• Cell Surface GlycoRNA–RBP Clusters Enable Peptide Entry Mech

  2026-04-29

  This study uncovers that RNA-binding proteins (RBPs) and glycoRNAs form organized nanoclusters on the cell surface, acting as entry points for cell-penetrating peptides such as TAT. The work advances understanding of cell surface organization, revealing a new layer of regulatory complexity in extracellular communication and peptide uptake.

• Honokiol as a Precision Tool: Quantitative Insights for In V

  2026-04-29

  Explore Honokiol—a bioactive small molecule and NF-κB pathway inhibitor—through the lens of advanced in vitro assay design, with a focus on evidence-based, quantitative assay interpretation and workflow optimization. This article reveals the compound’s unique strengths and limitations beyond standard mechanistic reviews.

• O-GlcNAcylation Drives Wnt-Stimulated Bone Formation via Gly

  2026-04-28

  This study uncovers how Wnt3a signaling promotes bone anabolism by rapidly inducing O-GlcNAcylation through both Ca2+-PKA-GFAT1 and Wnt–β-catenin pathways. The findings establish O-GlcNAcylation as a mechanistic link between Wnt signaling, metabolic rewiring, and osteoblast-driven bone formation, offering new insight for osteoporosis research and therapeutic strategies.

• RWJ 67657: Mechanistic Selectivity and Assay Implications in

  2026-04-28

  Explore the advanced selectivity and nuanced mechanism of RWJ 67657 in p38 MAP kinase signaling. This article uniquely connects conformational dynamics to assay choices, setting it apart in inflammatory disease research.

• DAPI Solution (1 mg/mL): Nuclear Staining and Chromatin Dyna

  2026-04-27

  Explore the advanced uses of DAPI (4',6-Diamidino-2-Phenylindole) Solution (1 mg/mL) for nuclear visualization, viability assessment, and apoptosis detection. This article bridges chromatin biology, tumor immunology, and state-of-the-art nuclear staining workflows, offering unique insights not covered in previous DAPI content.

• CX-4945 (Silmitasertib): Advanced Workflows for CK2 Inhibiti

  2026-04-27

  CX-4945 (Silmitasertib) empowers cancer and virology researchers to precisely inhibit CK2 with robust, reproducible protocols. New mechanistic evidence now extends its utility to antiviral studies, enabling strategic targeting of host-pathogen interactions.

• SB 431542: Precision ALK5 Inhibition in Stem Cell Differenti

  2026-04-26

  Explore the advanced use of SB 431542 as a potent ALK5 inhibitor in directing stem cell fate, with a special focus on TGF-β signaling modulation and its implications for regenerative medicine. Discover protocol insights and comparative perspectives unique to this article.

• Proteoform-Specific Drug Targeting in Native Cell Signaling

  2026-04-25

  This study pioneers the direct analysis of membrane protein–ligand interactions within native lipid bilayers, enabling the characterization of proteoform-specific drug interactions. The findings have major implications for the rational design of selective therapeutics and the assessment of off-target drug effects in physiological contexts.

• 12-O-tetradecanoyl Phorbol-13-acetate (TPA): Precision Contr

  2026-04-24

  Explore how 12-O-tetradecanoyl phorbol-13-acetate (TPA) enables mechanistically precise modulation of the ERK/MAPK and PKC pathways, with a focus on tumor immunology and antibody-dependent cytotoxicity. This article uniquely connects TPA’s molecular action to recent innovations in Fc receptor biology, advancing signal transduction research.

• Vemurafenib (PLX4032) in Melanoma Research: Protocols & Resi

  2026-04-24

  Vemurafenib (PLX4032) is a benchmark BRAF V600E inhibitor driving precision studies in melanoma cell proliferation inhibition and resistance network mapping. This article translates recent multi-omics breakthroughs into step-driven protocols, practical troubleshooting, and comparative strategies for advanced cancer biology research.

• Diclofenac: Non-Selective COX Inhibitor in Organoid Assays

  2026-04-23

  Harness Diclofenac, a high-purity non-selective COX inhibitor, to advance inflammation and pain signaling research using hiPSC-derived intestinal organoids. Discover workflow optimizations, troubleshooting essentials, and translational advantages that set this compound—and APExBIO as a supplier—apart in modern pharmacokinetic studies.

• H-89: Precision cAMP-Dependent Protein Kinase Inhibitor Appl

  2026-04-23

  H-89 empowers researchers to dissect cAMP signaling with exceptional selectivity, enabling reproducible modulation of PKA-dependent cellular pathways. Its proven efficacy in metabolic, osteogenic, and apoptosis research makes it indispensable for advanced signal transduction workflows.

• Trametinib (GSK1120212): Scenario-Driven Solutions in Oncolo

  2026-04-22

  This article provides a scenario-based exploration of real challenges in cell viability and cytotoxicity assays, demonstrating how Trametinib (GSK1120212), SKU A3018, offers reproducible, data-backed solutions for oncology researchers. Evidence-based Q&A blocks address assay optimization, data interpretation, and vendor selection, emphasizing the reliability and scientific rigor of Trametinib (GSK1120212) from APExBIO.

15822 records 1/1055 page Next 12345 下5页 Last page